p14ARF Deletion and Methylation in Genetic Pathways to Glioblastomas
- 5 April 2001
- journal article
- Published by Wiley in Brain Pathology
- Vol. 11 (2) , 159-168
Abstract
The CDKN2A locus on chromosome 9p21 contains the p14ARF and p16INK4a genes, and is frequently deleted in human neoplasms, including brain tumors. In this study, we screened 34 primary (de novo) glioblastomas and 16 secondary glioblastomas that had progressed from low‐grade diffuse astrocytomas for alterations of the p14ARF and p16INK4a genes, including homozygous deletion by differential PCR, promoter hypermethylation by methylation‐specific PCR, and protein expression by immunohistochemistry. A total of 29 glioblastomas (58%) had a p14ARF homozygous deletion or methylation, and 17 (34%) showed p16INK4a homozygous deletion or methylation. Thirteen glioblastomas showed both p14ARF and p16INK4a homozygous deletion, while nine showed only a p14ARF deletion. Immunohistochemistry revealed loss of p14ARF expression in the majority of glioblastomas (38/50, 76%), and this correlated with the gene status, i.e. homozygous deletion or promoter hypermethylation. There was no significant difference in the overall frequency of p14ARF and p16INK4a alterations between primary and secondary glioblastomas. The analysis of multiple biopsies from the same patients revealed hypermethylation of p14ARF (5/15 cases) and p16INK4a (1/15 cases) already at the stage of low‐grade diffuse astrocytoma but consistent absence of homozygous deletions. These results suggest that aberrant p14ARF expression due to homozygous deletion or promoter hypermethylation is associated with the evolution of both primary and secondary glioblastomas, and that p14ARF promoter methylation is an early event in subset of astrocytomas that undergo malignant progression to secondary glioblastoma.Keywords
This publication has 42 references indexed in Scilit:
- Immunolocalization of Human p14ARF to the Granular Component of the Interphase NucleolusExperimental Cell Research, 2000
- Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosisCancer Letters, 2000
- Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancerOncogene, 1999
- Deletions of the INK4A Gene in Superficial Bladder TumorsThe American Journal of Pathology, 1999
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16INK4a/MTS1 geneOncogene, 1997
- Cancer Cell CyclesScience, 1996
- MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9pHuman Molecular Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994
- Subsets of Glioblastoma Multiforme Defined by Molecular Genetic AnalysisBrain Pathology, 1993